Evidence map›Paper›PMID 21358639›Full record

ArticleNature immunology2011

The helminth product ES-62 protects against septic shock via Toll-like receptor 4-dependent autophagosomal degradation of the adaptor MyD88.

Padmam Puneet, Mairi A McGrath, Hwee Kee Tay, Lamyaa Al-Riyami, Justyna Rzepecka, Shabbir M Moochhala, Shazib Pervaiz, Margaret M Harnett, William Harnett, Alirio J Melendez

RetractedOpen access · goldAbstract readRetracted Publication
PubMed Publisher
In one paragraph

Article in Nature immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 37 citations in OpenAlex.

  1. Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Cathepsin L3 FromFrontiers in immunology · 2019
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Padmam PuneetDepartment of Physiology, National University of Singapore, Singapore.
Mairi A McGrath
Hwee Kee Tay
Lamyaa Al-Riyami
Justyna Rzepecka
Shabbir M Moochhala
Shazib Pervaiz
Margaret M Harnett
William Harnett
Alirio J Melendez
University of Glasgow · GBUniversity of Strathclyde · GBNational University of Singapore · SGDSO National Laboratories · SGMedical Research Council · GB

Funding

Biotechnology and Biological Sciences Research CouncilMedical Research Council G0700794Wellcome Trust
6 · The paper itself

Abstract

Sepsis is one of the most challenging health problems worldwide. Here we found that phagocytes from patients with sepsis had considerable upregulation of Toll-like receptor 4 (TLR4) and TLR2; however, shock-inducing inflammatory responses mediated by these TLRs were inhibited by ES-62, an immunomodulator secreted by the filarial nematode Acanthocheilonema viteae. ES-62 subverted TLR4 signaling to block TLR2- and TLR4-driven inflammatory responses via autophagosome-mediated downregulation of the TLR adaptor-transducer MyD88. In vivo, ES-62 protected mice against endotoxic and polymicrobial septic shock by TLR4-mediated induction of autophagy and was protective even when administered after the induction of sepsis. Given that the treatments for septic shock at present are inadequate, the autophagy-dependent mechanism of action by ES-62 might form the basis for urgently needed therapeutic intervention against this life-threatening condition.

Indexed as

AnimalsAutophagyCells, CulturedFemaleHelminth ProteinsHumansImmunoblottingInflammation MediatorsMacrophagesMaleMiceMice, Inbred C57BLMice, KnockoutMicroscopy, ConfocalMicroscopy, ElectronMyeloid Differentiation Factor 88ES-62 protein, Acanthocheilonema viteaeHelminth ProteinsInflammation MediatorsMyeloid Differentiation Factor 88Toll-Like Receptor 2Toll-Like Receptor 4

Identifiers

PMID21358639
OpenAlexW2104204979

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.